Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
02/2004
02/18/2004CN1138758C Tetrahydropyridines as pesticides
02/17/2004US6693202 Multibinding ligands containing such as amine, amide, ester, hydroxyl, carbamate, urea and/or imino functionality
02/17/2004US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter
02/17/2004US6693137 Sulphonamide derivatives
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6693118 E.G., 1-(2-(6,7-METHYLENEDIOXYNAPHTH-2-YL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE AND 1-2-(4-CYCLOHEXENYLPHENYL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6 -TETRAHYDROPYRIDINE; apoptosis inhibition; treatment of graft rejection or of acute or chronic rheumatoid arthritis
02/17/2004US6693117 Compounds with analgesic effect
02/17/2004US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol
02/17/2004US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
02/12/2004WO2004013282A2 Bis (amino acid) molecular scaffolds
02/12/2004WO2004013101A2 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
02/12/2004WO2004013100A2 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
02/12/2004WO2003101381A3 1,2 diamido cycloalkyl sodium channel blockers
02/12/2004WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
02/12/2004WO2003017948A3 Aryl tetrahydronaphthalene derivatives
02/12/2004WO2003010159A8 Piperidine derivatives as nmda receptor antagonists
02/12/2004WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
02/12/2004US20040030143 Calcium channel blockers; hypotensive agents; reacting phenylacetic acid, p-hydroxy- with amlodipine
02/12/2004US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient
02/12/2004US20040029931 Organic acid salt of amlodipine
02/12/2004US20040029923 Antiischemic agents; cardiovascular disorders
02/12/2004US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
02/12/2004US20040029917 Benzosuberonylpiperdine compounds as analgesics
02/12/2004US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders
02/12/2004US20040029883 Beta-amino acid compounds as integrin antagonists
02/12/2004US20040029880 Anthranyl amides and their use as medicaments
02/12/2004US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
02/12/2004US20040029862 Alzheimer's disease
02/12/2004US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents
02/12/2004US20040028752 Hemorrhoids therapy
02/11/2004EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
02/11/2004EP1299356B1 Novel compounds
02/11/2004EP1032561B1 Substituted oximes as neurokinin antagonists
02/11/2004EP0936912B1 Inhibitors of cysteine protease
02/11/2004CN1474810A Substituted urea neuropeptide YY5 antagonists
02/11/2004CN1474689A CDC25 phosphatase inhibitors
02/10/2004US6689898 For therapy of allergies
02/10/2004US6689795 Methods for treating dementia due to HIV disease
02/10/2004US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/10/2004US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
02/10/2004US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase
02/10/2004US6689765 Viricides; antiinflammatory agents
02/05/2004WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
02/05/2004WO2004011435A1 Organic acid salt of amlodipine
02/05/2004WO2004011434A1 Organic acid salt of amlodipine
02/05/2004WO2004011433A1 Organic acid salt of amlodipine
02/05/2004WO2004011432A1 Organic acid salt of amlodipine
02/05/2004WO2004011431A1 Pleuromutilin derivatives as antimicrobbials
02/05/2004WO2004011427A2 Substituted benzanilides as modulators of the ccr5 receptor
02/05/2004WO2004011410A1 Chemical compounds
02/05/2004WO2004010943A2 Substituted benzanilides as modulators of the ccr5 receptor
02/05/2004WO2003075857A3 Amino-methyl substituted tetracycline compounds
02/05/2004US20040024218 Novel compounds
02/05/2004US20040024210 New compounds
02/05/2004US20040024059 Novel pleuromutilin derivatives
02/05/2004US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications
02/05/2004US20040024037 Includes a colorant, a solvent and an antibiotic additive produced by binding antibiotic substance to predetermined additive via chemical reaction; improves storage stability and inhibits propagation and growth of bacteria in ink
02/05/2004US20040024025 Compositions and methods for inducing cell death
02/05/2004US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases
02/05/2004US20040024021 Heatless separation via precipitation of diastereomeric salts with tartaric acid; improved anesthetics
02/05/2004US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi.
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes
02/05/2004US20040022856 Carriers for drug delivery
02/05/2004DE10231627A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
02/05/2004CA2494668A1 Chemical compounds
02/04/2004EP1386607A1 Process for the preparation of Donepezil
02/04/2004EP1385971A2 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
02/04/2004EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/04/2004EP1385824A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
02/04/2004EP1385818A2 Biurethane derivatives
02/04/2004EP1385506A2 Acylated piperidine derivates as melanocortin-4 receptor agonists
02/04/2004EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors
02/04/2004EP1030839B1 Use of alkylated iminosugars to treat multidrug resistance
02/04/2004EP0684816B1 5-ht2 receptor antagonists for treating venous conditions
02/04/2004CN1473152A Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same
02/04/2004CN1137096C Method for producing(-1) Cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine
02/04/2004CN1137095C Preparation of i(N)-substituted-hydroxycycloalkylamine derivatives
02/04/2004CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them
02/03/2004US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals
02/03/2004US6686424 Preparation of functionalized alkoxyamine initiator and its use
02/03/2004US6686377 For therapy of pain
02/03/2004US6686357 Benzimidazolo-piperidine compound
02/03/2004US6686350 Cell adhesion inhibitors
02/03/2004US6686182 Alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates
02/03/2004US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents
01/2004
01/29/2004WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1
01/29/2004WO2004009549A2 Piperidines useful for the treatment of central nervous system disorders
01/29/2004WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto
01/29/2004US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
01/29/2004US20040019117 Anti tubercular drug: compostions and methods
01/29/2004US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase
01/29/2004US20040019083 Amino acid derivatives; antineoplastic agents
01/29/2004US20040019082 Reversible infertility in male mice following oral administration of alkylated imino sugars: a non-hormonal approach to male contraception
01/29/2004US20040019081 2, 6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storage
01/29/2004US20040019017 Caspase inhibitor prodrugs
01/29/2004US20040018598 Chemical intermediate for discodermolide, epothilone
01/29/2004CA2492651A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1
01/28/2004EP1384720A1 Process for drying paroxetine hydrochloride
01/28/2004EP1384711A1 Optical resolution of a piperidine derivative
01/28/2004EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor